日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma.

UBE2N 作为肺腺癌的新型预后和治疗生物标志物

Yin Haofeng, Xue Yibo, Wang Chen, Wu Yanqin, Guo Yuchen, Li Chunzhen, Zhang Yunyan, Yin Shulei, Zhao Tiejun

Itaconate facilitates viral infection via alkylating GDI2 and retaining Rab GTPase on the membrane

衣康酸通过烷基化GDI2并将Rab GTP酶保留在细胞膜上来促进病毒感染。

Yin, Shulei; Tao, Yijie; Li, Tianliang; Li, Chunzhen; Cui, Yani; Zhang, Yunyan; Yin, Shenhui; Zhao, Liyuan; Hu, Panpan; Cui, Likun; Wu, Yunyang; He, Yixian; Yu, Shu; Chen, Jie; Lu, Shaoteng; Qiu, Guifang; Song, Mengqi; Hou, Qianshan; Qian, Cheng; Zou, Zui; Xu, Sheng; Yu, Yizhi

Comprehensive single-cell and bulk transcriptomic analyses to develop an NK cell-derived gene signature for prognostic assessment and precision medicine in breast cancer.

进行全面的单细胞和批量转录组分析,以开发 NK 细胞衍生的基因特征,用于乳腺癌的预后评估和精准医疗

Hou Qianshan, Li Chunzhen, Chong Yuhui, Yin Haofeng, Guo Yuchen, Yang Lanjie, Li Tianliang, Yin Shulei

A Novel Tumor-Associated Neutrophil-Related Risk Signature Based on Single-Cell and Bulk RNA-Sequencing Analyses Predicts the Prognosis and Immune Landscape of Breast Cancer

基于单细胞和批量RNA测序分析的新型肿瘤相关中性粒细胞风险特征可预测乳腺癌的预后和免疫图谱

Yin, Shulei; Li, Chunzhen; Zhang, Yunyan; Yin, Haofeng; Fan, Zhezhe; Ye, Xibo; Hu, Han; Li, Tianliang